SCI Abstract

search
+
Emicizumab in previously untreated and minimally treated infants
Emicizumab in previously untreated and minimally treated infants
Early View LETTER TO THE EDITOR Eman Hassan, Corresponding Author Eman...
Mental health disorders and health‐related quality of life in adults with inherited bleeding disorders in central South Africa
Mental health disorders and health‐related quality of life in adults with inherited bleeding disorders in central South Africa
Corresponding Author Marius J. Coetzee Department of Haema...
Do we need all that emicizumab?
Do we need all that emicizumab?
Early View LETTER TO THE EDITOR Anna-Elina Lehtinen, Anna-Elina Lehtinen ...
Acquired haemophilia A: Insight into treatment and outcomes from an Australian tertiary referral centre
Acquired haemophilia A: Insight into treatment and outcomes from an Australian tertiary referral centre
James D McFadyen Department of Clinical Haematology, The Alfred Hospital, Melbo...
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype
Abstract Introduction The negative impact of haemophilia on social participation is well established in previous studies, ...
Pain memories: A new concept to consider in the management of chronic pain in people with haemophilia
Pain memories: A new concept to consider in the management of chronic pain in people with haemophilia
Corresponding Author Anna J. Wells Haemophilia, Haemostasi...
Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol
Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol
Di Ai Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Dis...
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
Abstract Introduction The development of inhibitory antibodies is a severe complication of clotting factor replacement the...
Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset
Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset
Abstract Introduction Obesity is associated with endothelial dysfunction, haemostatic and fibrinolytic disturbances, howev...
Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study
Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study
Early View LETTER TO THE EDITOR Anna Buczma, Department of Hemostasis Disorders and I...
The relationship between chronic pain and psychosocial aspects in patients with haemophilic arthropathy. A cross‐sectional study
The relationship between chronic pain and psychosocial aspects in patients with haemophilic arthropathy. A cross‐sectional study
Abstract Background Pain is a major characteristic in haemophilic arthropathy. Identifying the psychosocial variables affe...
Determining causes of death among individuals with haemophilia in Afghanistan
Determining causes of death among individuals with haemophilia in Afghanistan
Abstract Introduction Haemophilia is a well-known bleeding disorder that affects people worldwide. The main therapeutic st...
Off‐label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature
Off‐label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature
Abstract Introduction Since the approval of emicizumab, a bispecific, factor VIII-mimetic antibody, for use in person...
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?
Early View LETTER TO THE EDITOR Eman Hassan, Corresponding Author Depa...
Is immune tolerance induction conceivable in haemophilia with inhibitors in a low‐middle income country? Real‐world data from Tunisia
Is immune tolerance induction conceivable in haemophilia with inhibitors in a low‐middle income country? Real‐world data from Tunisia
Corresponding Author emnahammami1993@gmail.com orcid.org/0...
Clinical outcomes after joint surgery in patients on turoctocog alfa pegol (N8‐GP) prophylaxis: A post hoc analysis
Clinical outcomes after joint surgery in patients on turoctocog alfa pegol (N8‐GP) prophylaxis: A post hoc analysis
Abstract Introduction Joint damage in haemophilia often requires surgical correction. However, the surgery effect on bleed...
Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study
Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study
Abstract Introduction Oral health is an important component of care at haemophilia treatment centres (HTCs). Correlations ...
Low‐dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success
Low‐dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success
Abstract Introduction Immune Tolerance Induction (ITI) is the first-choice therapy to eradicate Factor VIII (FVIII) neutra...
Vaccination in children with inherited bleeding disorders: Does the use of plasma an d factor affect the response to the vaccine: An institutional registry
Vaccination in children with inherited bleeding disorders: Does the use of plasma an d factor affect the response to the vaccine: An institutional registry
Abstract Introduction We aimed to evaluate the vaccine seroconversion of paediatric patients with factor deficiency and to...
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
Abstract Introduction Turoctocog alfa (NovoEight®) is a B-domain-truncated recombinant factor VIII (FVIII) approved f...
Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers
Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers
Abstract Introduction The Haemophilia Experiences, Results and Opportunities (HERO) Study identified sexual health as an i...
Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature
Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature
Abstract Introduction Treatment of patients with Haemophilia A has improved significantly in recent years since the advent...
A distinct common p.Gln317* mutation among causative LMAN1 genetic mutations of combined factor V and factor VIII deficiency in five Taiwanese families
A distinct common p.Gln317* mutation among causative LMAN1 genetic mutations of combined factor V and factor VIII deficiency in five Taiwanese families
Corresponding Author Division of Haematology/Oncology, Department of Internal M...
Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender
Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender
Molecular Diagnostic Laboratory, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada ...
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B‐LONG using haemophilia‐specific quality of life questionnaires
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B‐LONG using haemophilia‐specific quality of life questionnaires
Abstract Introduction Recurrent bleeding in severe haemophilia B causes painful hemarthroses and reduces capacity for phys...
Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database
Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database
Abstract Introduction Von Willebrand disease (VWD) is the most common inherited bleeding disorder. The bleeding phenotype ...
Excess weight gain in the paediatric bleeding disorders population: Impact of the COVID‐19 Pandemic
Excess weight gain in the paediatric bleeding disorders population: Impact of the COVID‐19 Pandemic
Abstract Introduction The COVID-19 pandemic has resulted in lifestyle changes for children. The aim of this study was to e...
Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3‐decade retrospective review
Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3‐decade retrospective review
Abstract Introduction Haemophilic arthropathy is a serious complication of haemophilia often requiring surgical interventi...
Efficacy and safety evaluation of Fanhdi®, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
Efficacy and safety evaluation of Fanhdi®, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
Corresponding Author Department of Hematology and Hemotherapy, Hospital Univers...
In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients
In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients
Abstract Background Heparin management in hemophilia A (HA) patients with a factor VIII (FVIII) inhibitor can be challengi...
Load More
format_indent_increase